THROMBIN MODULATES SYNTHESIS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 BY HUMAN PERIPHERAL-BLOOD MONOCYTES

Fibrin deposition is characteristic of inflammatory diseases, The monocyte is central to the inflammatory response and can affect fibrinolysis by expression of urokinase (u-PA) and plasminogen activator inhibitor types 1 and 2 (PAI-1 and PAI-2, respectively), This study examines whether thrombin, which promotes fibrin deposition, can contribute to fibrin persistence by modulating expression of proteins of the fibrinolytic system, Monocytes were isolated from human peripheral blood and analyzed for PAI-2, PAI-1, and u-PA antigens by enzyme-linked immunosorbent assay (ELISA), Monocytes responded to thrombin by increased expression of PAI-2 in a dose- and time-dependent manner, with maximal synthesis at a concentration of 1 U/mL to 10 U/mL. This trend was also evident for PAI-1, which was present at much lower levels. Thrombin and lipopolysaccharide (LPS) stimulated comparable levels of PAI-2, studied at the antigen and mRNA level, The dose effect of LPS on PAI-2 and PAI-1 was found to differ from that of thrombin, The level of u-PA was undetectable by ELISA and zymography in all samples, Thrombin stimulates PAI-2 synthesis by human monocytes, therefore creating an imbalance in the fibrinolytic system, This may contribute to persistence of fibrin, deposited during inflammation. (C) 1995 by The American Society of Hematology.